tiprankstipranks
Trending News
More News >
HTG Molecular Diagnostics (HTGMQ)
OTHER OTC:HTGMQ
US Market

HTG Molecular Diagnostics (HTGMQ) Ratios

Compare
460 Followers

HTG Molecular Diagnostics Ratios

HTGMQ's free cash flow for Q1 2023 was $-0.11. For the 2023 fiscal year, HTGMQ's free cash flow was decreased by $ and operating cash flow was $-4.76. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
1.89 2.73 4.54 4.65-
Quick Ratio
1.78 2.53 4.34 4.51-
Cash Ratio
1.48 0.97 3.10 0.86-
Solvency Ratio
-1.70 -0.80 -0.91 -0.83-
Operating Cash Flow Ratio
-2.23 -1.66 -2.25 -1.88-
Short-Term Operating Cash Flow Coverage
-4.83 -3.19 -5.39 -5.59-
Net Current Asset Value
$ 3.27M$ 7.13M$ 12.16M$ 20.22M-
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.38 0.36 0.25-
Debt-to-Equity Ratio
0.90 1.13 0.87 0.47-
Debt-to-Capital Ratio
0.47 0.53 0.47 0.32-
Long-Term Debt-to-Capital Ratio
0.39 0.47 0.37 0.32-
Financial Leverage Ratio
3.30 2.93 2.43 1.88-
Debt Service Coverage Ratio
-4.32 -2.47 -4.52 -4.37-
Interest Coverage Ratio
-24.31 -16.74 -19.11 -19.80-
Debt to Market Cap
33.17K 5.68 7.85 8.06-
Interest Debt Per Share
6.40 22.10 35.44 57.70-
Net Debt to EBITDA
0.37 -0.14 0.53 -0.21-
Profitability Margins
Gross Profit Margin
28.18%54.02%53.31%53.60%-
EBIT Margin
-325.58%-180.29%-231.97%-95.48%-
EBITDA Margin
-316.35%-172.41%-213.73%-89.80%-
Operating Profit Margin
-327.19%-200.11%-229.10%-98.73%-
Pretax Profit Margin
-339.03%-192.24%-243.96%-100.47%-
Net Profit Margin
-339.20%-192.49%-244.13%-100.49%-
Continuous Operations Profit Margin
-339.20%-192.49%-244.13%-100.49%-
Net Income Per EBT
100.05%100.13%100.07%100.02%-
EBT Per EBIT
103.62%96.07%106.49%101.76%-
Return on Assets (ROA)
-121.47%-56.29%-59.29%-42.77%-
Return on Equity (ROE)
-273.49%-164.86%-144.08%-80.51%-
Return on Capital Employed (ROCE)
-219.10%-86.87%-70.04%-52.35%-
Return on Invested Capital (ROIC)
-151.07%-68.38%-61.89%-47.45%-
Return on Tangible Assets
-121.47%-56.29%-59.29%-42.77%-
Earnings Yield
-24282991.71%-683.47%-1412.94%-1082.79%-
Efficiency Ratios
Receivables Turnover
4.48 4.26 5.38 6.07-
Payables Turnover
3.95 2.48 2.96 5.36-
Inventory Turnover
5.03 2.06 2.68 7.02-
Fixed Asset Turnover
3.97 3.61 3.82 5.57-
Asset Turnover
0.36 0.29 0.24 0.43-
Working Capital Turnover Ratio
0.52 0.42 0.29 0.61-
Cash Conversion Cycle
61.70 115.90 80.94 44.05-
Days of Sales Outstanding
81.51 85.75 67.83 60.14-
Days of Inventory Outstanding
72.59 177.18 136.45 52.00-
Days of Payables Outstanding
92.40 147.02 123.34 68.10-
Operating Cycle
154.10 262.92 204.28 112.14-
Cash Flow Ratios
Operating Cash Flow Per Share
-20.70 -28.56 -42.25 -78.88-
Free Cash Flow Per Share
-20.73 -29.68 -43.42 -84.09-
CapEx Per Share
0.03 1.11 1.18 5.21-
Free Cash Flow to Operating Cash Flow
1.00 1.04 1.03 1.07-
Dividend Paid and CapEx Coverage Ratio
-798.81 -25.62 -35.92 -15.13-
Capital Expenditure Coverage Ratio
-798.81 -25.62 -35.92 -15.13-
Operating Cash Flow Coverage Ratio
-3.81 -1.41 -1.29 -1.48-
Operating Cash Flow to Sales Ratio
-2.89 -1.85 -1.91 -0.87-
Free Cash Flow Yield
-8339744.34%-683.78%-1133.72%-998.71%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -0.15 -0.07 -0.09-
Price-to-Sales (P/S) Ratio
<0.01 0.28 0.17 0.09-
Price-to-Book (P/B) Ratio
<0.01 0.24 0.10 0.07-
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -0.15 -0.09 -0.10-
Price-to-Operating Cash Flow Ratio
>-0.01 -0.15 -0.09 -0.11-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 <0.01 <0.01-
Price-to-Fair Value
<0.01 0.24 0.10 0.07-
Enterprise Value Multiple
0.37 -0.30 0.45 -0.31-
Enterprise Value
-7.38M 4.62M -8.28M 5.42M-
EV to EBITDA
0.37 -0.30 0.45 -0.31-
EV to Sales
-1.16 0.52 -0.97 0.28-
EV to Free Cash Flow
0.40 -0.27 0.49 -0.30-
EV to Operating Cash Flow
0.40 -0.28 0.51 -0.32-
Tangible Book Value Per Share
6.06 17.99 37.56 113.24-
Shareholders’ Equity Per Share
6.06 17.99 37.56 113.24-
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01-
Revenue Per Share
7.16 15.41 22.17 90.73-
Net Income Per Share
-24.28 -29.66 -54.12 -91.17-
Tax Burden
1.00 1.00 1.00 1.00-
Interest Burden
1.04 1.07 1.05 1.05-
Research & Development to Revenue
1.07 0.68 0.71 0.55-
SG&A to Revenue
0.00 0.00 0.00 0.00-
Stock-Based Compensation to Revenue
0.13 <0.01 <0.01 <0.01-
Income Quality
0.85 0.96 0.78 0.87-
Currency in USD